Peginesatide acetate

N/A

Report date: 2023/04/19 18:00:49
NME

Base Information

Drug NamePeginesatide acetate
Drug Alias Name醋酸培尼沙肽Omontys preservative freeHematideOmontysAF-37702 +[6] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsRed-Cell Aplasia, PureAnemiaRenal Insufficiency, Chronic +[5] 
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2012/03/27
Country/TerritoryCzechiaBulgariaUnited States +[15] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAffymax IncorporatedTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Pharmaceuticals USA IncAffymax IncorporatedTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsRed-Cell Aplasia, PureAnemiaRenal Insufficiency, Chronic +[5] 

Other Information

ATC CodeB03XA04
Related LinksWikipediaDrugBankKEGG